Pancreatic Cancer
|4 min read
AACR Cancer Progress Report 2026 Highlights Advances in Cancer Research and Care
The 16th annual report details new cancer therapeutics, improving survival rates, and emerging technologies, including artificial intelligence, cancer vaccines, and RNA therapies|2 min read
Amplified Sciences Achieves CAP Accreditation for Cutting-Edge Diagnostic Lab
Gold standard milestone clears the path for national expansion of PanCystPro™ assay|2 min read
Amplified Sciences Earns CLIA Certification for Its First Test to Assess Pancreatic Cancer Risk
Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025|3 min read
New Research Suggests How to Improve Effectiveness of KRAS Inhibitors in Pancreatic Cancer
New research in mouse models has uncovered a new mechanism of resistance to KRAS inhibitors|3 min read
New Hope for Early Detection and Prevention of Pancreatic Cancer
New findings suggest pathway for screening high-risk individuals for pancreatic cancer in PRECEDE studyUpdated |3 min read
Novel Exosome-Based Liquid Biopsy Detects Pancreatic Cancer
When combined with CA 19-9, the novel biopsy accurately detected 97 percent of stage 1–2 pancreatic cancers|2 min read
Vaccine Candidate Delays Relapse of KRAS-Mutated Cancers
All patients receiving the highest dose had significant T-cell responses, correlating with a significant reduction in risk of relapse|2 min read
Treatment-Trio Shows Promise in Patients with Pancreatic Cancers
Combination therapy improved median disease-free and overall survival in pancreatic ductal adenocarcinoma cases|3 min read
Pancreatic Lesions May Occur Earlier than Previously Thought
Researchers partnered with Gift Of Life Michigan to analyze healthy pancreata from deceased donors|5+ min read
NIH Releases Annual Report to the Nation
Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer|2 min read
New Guidelines for Pancreatic Cancer Screening
The new guidelines expand indication for screening for all with the gene variations regardless of family history|3 min read


















